NCT00182156

Brief Summary

This study is examining the effects of short daily hemodialysis on platelet function, fluid volume control, arterial stiffness and patient quality of life, as compared to conventional hemodialysis.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2004

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2004

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2005

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2005

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

April 15, 2022

Status Verified

April 1, 2022

Enrollment Period

4.2 years

First QC Date

September 10, 2005

Last Update Submit

April 10, 2022

Conditions

End-stage Renal DiseaseThrombocytopathyCardiovascular Diseases

Keywords

hemodialysisplatelet function analyzerbioimpedancepulse wave velocityend stage renal disease

Study Arms (3)

1

conventional HD

2

short daily HD

3

PD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Short daily HD v PD v conventional HD

You may qualify if:

  • Patient is enrolled in short daily hemodialysis program
  • Patient is minimum of 18 years old

You may not qualify if:

  • Patient is unable to consent due to language barrier
  • Patient is unable to consent due to cognitive difficulties
  • Patient refuses consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Joseph's Healthcare

Hamilton, Ontario, L8N 4A6, Canada

Location

MeSH Terms

Conditions

Kidney Failure, ChronicBlood Platelet DisordersCardiovascular Diseases

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Azim Gangji, MD

    Clinical Scholar, Medicine

    PRINCIPAL INVESTIGATOR

  • Catherine M Clase, MD

    Associate Professor, Medicine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 10, 2005

First Posted

September 16, 2005

Study Start

October 1, 2004

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

April 15, 2022

Record last verified: 2022-04

Locations

CA(1)